Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Accenture
Deloitte
Colorcon
Federal Trade Commission
Fish and Richardson
Boehringer Ingelheim
Queensland Health
McKinsey

Generated: November 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022025

« Back to Dashboard

NDA 022025 describes TOTECT, which is a drug marketed by Clinigen Hlthcare and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the TOTECT profile page.

The generic ingredient in TOTECT is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.
Summary for 022025
Tradename:TOTECT
Applicant:Clinigen Hlthcare
Ingredient:dexrazoxane hydrochloride
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 022025
Medical Subject Heading (MeSH) Categories for 022025
Suppliers and Packaging for NDA: 022025
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOTECT dexrazoxane hydrochloride INJECTABLE;INJECTION 022025 NDA Cumberland Pharmaceuticals Inc. 66220-110 66220-110-01 1 VIAL, SINGLE-USE in 1 CARTON (66220-110-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:Sep 6, 2007TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Mar 13, 2020Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF EXTRAVASATION RESULTING FROM IV ANTHRACYCLINE CHEMOTHERAPY

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Accenture
Moodys
Argus Health
QuintilesIMS
Johnson and Johnson
Baxter
Fish and Richardson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.